Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep550 | Thyroid | ECE2024

Clinical case of a combination of giant prolactinoma and medullary thyroid cancer

Perepelova Margarita , Przhiyalkovskaya Elena , Pigarova Ekaterina , Nikiforovich Petr , Selivanova Lilia , Roslyakova Anna , Shutova Aleksandra , Dzeranova Larisa

Background: The combination of various endocrine tumours is presented both as hereditary syndromes and sporadic forms. Medullary thyroid cancer and prolactinoma are neuroendocrine tumours, the presence of these two pathologies simultaneously has not been previously described in the literature.Objective: To present a clinical case of a patient with giant prolactinoma and medullary thyroid cancer.Materials and Methods: To describe th...

ea0099ep610 | Thyroid | ECE2024

Combination of primary and secondary myopathy in a patient with severe hypothyroidism

Perepelova Margarita , Slokva Valeria , Pigarova Ekaterina , Shutova Aleksandra , Kolodkina Anna , Dzeranova Larisa

Background: One of the complications of hypothyroidism is the disorder of the neuromuscular system. Myopathic changes often accompany hypothyroidism and are observed in 30-80% of patients. A distinctive feature of hypothyroid myopathies is the reversibility of clinical manifestations and significant improvement of well-being after levothyroxine compensation of the disease. However, the absence of a vivid clinical picture of hypothyroidism, combined with its rare occurrence, co...

ea0099ep1297 | Late Breaking | ECE2024

The efficacy of pasireotide treatment in invasive crooke’s cell corticotropinoma – case report

Maliszewska Katarzyna , Poplawska-Kita Anna , Januszewska-Gilis Aleksandra , Witek Przemyslaw , Lyson Tomasz , Kretowski Adam

Introduction: Crooke’s cell adenomas (CCA) are a rare type of pituitary neoplasm, associated with Cushing’s disease. They are characterised by accumulation of perinuclear cytokeratin filaments, appearing distinctly hyaline in hematoxylin and eosin (HE) staining (Crooke’s hyaline change). Due to their rarity, the management and treatment remain a challenge.Clinical case: A 33-year-old male patient, presented sudden visual impairment, no sig...

ea0040p6 | (1) | ESEBEC2016

Toxicity of tyrosine kinase inhibitors in the treatment of thyroid cancer – a 10-year experience resume

Krajewska Jolanta , Kukulska Aleksandra , Paliczka-Cieślik Ewa , Handkiewicz-Junak Daria , Gawlik Tomasz , Olczyk Tomasz , Kropińska Aleksandra , Michalik Barbara , Gubała Elżbieta , Jarząb Barbara

Targeted therapy based on tyrosine kinase inhibitors (TKIs) constitutes a new treatment modality in thyroid cancer (TC). Their efficacy in prolongation of progression free survival in comparison to placebo has been documented in phase III studies. However, a problem of their tolerability has recently risen as numerous side effects influencing the quality of life may potentially limit their clinical use. Therefore, we decided to carry out a retrospective analysis of the frequen...

ea0037ep209 | Reproduction, endocrine disruptors and signalling | ECE2015

The commonly used plasticisers (bisphenols and phthalates) as endocrine disrupting chemicals in healthy women and women with polycystic ovary syndrome

Rutkowska Aleksandra , Konieczna Aleksandra , Wilczewska Kamila , Ciechanowicz Agnieszka , Czernych Radoslaw , Kowalewska-Wlas Agnieszka , Laczmanski Lukasz , Kuliczkowska Justyna , Lenarcik Agnieszka , Trzmiel-Bira Anna , Brona Anna , Kuligowska-Jakubowska Monika , Kot-Wasik Agata , Wasik Andrzej , Milewicz Andrzej , Namiesnik Jacek , Wolska Lidia , Rachon Dominik

Plasticisers such as bisphenol A (BPA), bisphenol S (BPS), and phthalates (PAE) are commonly used in daily life in electronic equipment, cans, plastic food containers, and bottles. These substances can interact with oestrogen receptors as well as androgen receptors and therefore they are called endocrine disrupting chemicals (EDC). The aim of this study was to evaluate serum concentrations of BPA, BPS, and selected PAE in healthy women and women with polycystic ovary syndrome ...

ea0035oc5.5 | Adrenal & Thyroid | ECE2014

Validation of follicular thyroid cancer molecular classifier in fine-needle aspiration biopsy samples

Pfeifer Aleksandra , Bartosz Wojtas , Malgorzata Oczko-Wojciechowska , Aleksandra Kukulska , Agnieszka Czarniecka , Markus Eszlinger , Thomas Musholt , Tomasz Stokowy , Ewa Stobiecka , Jolanta Krajewska , Dagmara Rusinek , Tomasz Tyszkiewicz , Monika Kowal , Michal Jarzab , Steffen Hauptmann , Dariusz Lange , Ralf Paschke , Barbara Jarzab

Introduction: Follicular adenomas (FTA) and carcinomas (FTC) are thyroid tumours that are indistinguishable in the fine needle aspiration biopsy (FNAB). In our previous research we concentrated on post-operative material and developed the classifier, which discriminates the FTC and FTA, based on formalin-fixed paraffin-embedded (FFPE) material. The classifier was based on expression of five genes and gave the promising sensitivity of 71% and specificity of 72%. The aim of the ...

ea0035p511 | Endocrine disruptors | ECE2014

The potential role of bisphenol A in the pathogenesis of polycystic ovary syndrome

Rutkowska Aleksandra , Wilczewska Kamila , Laczmanski Lukasz , Kuliczkowska Justyna , Lenarcik Agnieszka , Trzmiel-Bira Anna , Brona Anna , Kuligowska-Jakubowska Monika , Konieczna Aleksandra , Kot-Wasik Agata , Wasik Andrzej , Milewicz Andrzej , Namiesnik Jacek , Rachon Dominik

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age, that lead to infertility, type 2 diabetes and coronary heart disease.Bisphenol A (BPA) is one of the most abundant chemicals produced worldwide and is used as a plasticizer in daily life. Nowadays it is also well know that it can interact with estrogen receptors, androgen receptors and peroxisome proliferator-activated receptors γ (PPARγ). Therefore...

ea0070ep376 | Reproductive and Developmental Endocrinology | ECE2020

Thyroid peroxidase antibodies in women with polycystic ovary syndrome and type 1 diabetes

Lebkowska Agnieszka , Adamska Agnieszka , Krentowska Anna , Uruska Aleksandra , Rogowicz-Frontczak Anita , Araszkiewicz Aleksandra , Hryniewicka Justyna , Leśniewska Monika , Ożegowska Katarzyna , Wender-Ożegowska Ewa , Zozulinska-Ziolkiewicz Dorota , Kowalska Irina

Objective: Polycystic ovary syndrome (PCOS) is more prevalent among women with type 1 diabetes (T1DM) than in general population. Autoimmune thyroiditis (AIT) is the most common autoimmunological disease in young women in reproductive age, especially in T1DM. Data in literature indicate the possible role of thyroid autoimmunity in PCOS pathogenesis. It has been suggested that positive concentration of thyroid peroxidase antibodies (TPOAbs) is associated with increased prevalen...

ea0081p177 | Pituitary and Neuroendocrinology | ECE2022

Use of corrected SUVmax as a prognostic indicator of response to PRRT

Opalinska Marta , Sowa-Staszczak Anna , Kania-Kuc Adrian , Al Maraih Ibraheem , Gilis-Januszewska Aleksandra , Hubalewska-Dydejczyk Alicja

Background: PRRT is an effective treatment option (especially for controlling disease progression)for disseminated neuroendocrine tumors (NETs), with good expression of the somatostatin receptors. Despite significant progress in NET personalized management, searching for novel predictive and prognostic factors of response to PRRT is crucial for more effective follow-up, better treatment choices leading to more favorable final outcome. Some recent studies indicate that the resp...

ea0081p690 | Pituitary and Neuroendocrinology | ECE2022

Clinical characteristics at diagnosis and diagnostic delay among newly-diagnosed patients with acromegaly- single-center, pilot study

Godlewska Magdalena , Bogusławska Anna , Kluczyński Łukasz , Rzepka Ewelina , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Introduction: Diagnostic delay remains significant among the patients with acromegaly, even though the disease awareness has improved over the years.Aim: The aim was to investigate the diagnostic delay and symptoms present at diagnosis of acromegaly among the newly-diagnosed patients.Material and methods: 72 consecutive patients diagnosed with acromegaly between 01.2014 and 12.2021 were evaluated. Division into groups based on: gen...